Background A cross-talk between certain oncogenic signaling pathways and PD-L1 expression is emerging. Oncogenic signals often promote cell proliferation, an aggressive cancer hallmark, thus we hypothesized that tumor proliferation rates can influence the levels of PD-L1. Methods We used U251MG and SF767MG glioma cell lines that constitutively express PD-L1 and analyzed the expression level of PD-L1 in condition of serum deprivation and during the phases of cell culture growth. Also, we investigated whether tumor proliferative rates influenced the subcellular distribution of FKBP51s cochaperone, that regulates PD-L1 expression at translational level. Result Our findings suggested that PD-L1 upregulation was associated with DNA synthesis. FK...
FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously iden...
Glioblastoma can avoid immune surveillance and induce tumor tolerance, through inhibitory molecules,...
Among the high-grade malignant gliomas (III-IV), grade IV glioma, or glioblastoma (GBM), is the most...
Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment w...
peer reviewedDespite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1)...
Glioblastoma Multiforme is one of the most aggressive form of malignancy of the central nervous syst...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
PD-L1 antibodies produce efficacious clinical responses in diverse human cancers, but the basis for ...
The expression of PD-L1 by tumor cells is mainly associated with its immunosuppressive effect. In fa...
Cancer cells expressing PD-1 ligands (PD-L1/PD-L2) inhibit immune-modulatory T-cell activation facil...
PD-1 (Programmed Death Receptor-1) is a cell membrane protein found on Cytotoxic T cells (CTLs) surf...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
SummaryRecent clinical results for PD-1 blockade therapy have demonstrated durable tumor control wit...
The development of immune checkpoint blockade therapy has ushered in a new era of cancer treatment. ...
The expression of programmed death ligand-1 (PD-L1) is controlled by complex mechanisms. The elucida...
FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously iden...
Glioblastoma can avoid immune surveillance and induce tumor tolerance, through inhibitory molecules,...
Among the high-grade malignant gliomas (III-IV), grade IV glioma, or glioblastoma (GBM), is the most...
Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment w...
peer reviewedDespite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1)...
Glioblastoma Multiforme is one of the most aggressive form of malignancy of the central nervous syst...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
PD-L1 antibodies produce efficacious clinical responses in diverse human cancers, but the basis for ...
The expression of PD-L1 by tumor cells is mainly associated with its immunosuppressive effect. In fa...
Cancer cells expressing PD-1 ligands (PD-L1/PD-L2) inhibit immune-modulatory T-cell activation facil...
PD-1 (Programmed Death Receptor-1) is a cell membrane protein found on Cytotoxic T cells (CTLs) surf...
Gliomas aberrantly express programmed cell death ligand-1 (PD-L1), which has a pivotal role in immun...
SummaryRecent clinical results for PD-1 blockade therapy have demonstrated durable tumor control wit...
The development of immune checkpoint blockade therapy has ushered in a new era of cancer treatment. ...
The expression of programmed death ligand-1 (PD-L1) is controlled by complex mechanisms. The elucida...
FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously iden...
Glioblastoma can avoid immune surveillance and induce tumor tolerance, through inhibitory molecules,...
Among the high-grade malignant gliomas (III-IV), grade IV glioma, or glioblastoma (GBM), is the most...